Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Thrombosis and Stroke

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

N Engl J Med.

Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM; APEX Investigators.

doi: 10.1056/NEJMoa1601747

Heart Failure

Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization

JACC Heart Fail.

Bhagat AA, Greene SJ, Vaduganathan M, Fonarow GC, Butler J

doi: 10.1016/j.jchf.2018.06.011.

Heart Failure

Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study

JAMA Cardiol.

Kytömaa S, Hegde S, Claggett B, Udell JA, Rosamond W, Temte J, Nichol K, Wright JD, Solomon SD, Vardeny O

doi: 10.1001/jamacardio.

Cardiac Arrest or Death

In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study

BMJ

Hayek SS, Brenner SK, Azam TU, Shadid HR, Anderson E, Berlin H, Pan M, Meloche C, Feroz R, O'Hayer P, Kaakati R, Bitar A, Padalia K, Perry D, Blakely P, Gupta S, Shaefi S, Srivastava A, Charytan DM, Bansal A, Mallappallil M, Melamed ML, Shehata AM, Sunderram J, Mathews KS, Sutherland AK, Nallamothu BK, Leaf DE, STOP-COVID Investigators., STOP-COVID Investigators.

doi: 10.1136/bmj.m3513

Hypertension

Pro Re Nata Antihypertensive Medications and Adverse Outcomes in Hospitalized Patients: A Propensity-Matched Cohort Study

Hypertension

Mohandas R, Chamarthi G, Bozorgmehri S, Carlson J, Ozrazgat-Baslanti T, Ruchi R, Shukla A, Kazory A, Bihorac A, Canales M, Segal MS

doi: 10.1161/HYPERTENSIONAHA.121.17279

Atrial FibrillationTherapy and Intervention

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Circulation

Gibson CM, Pinto DS, Chi G, Arbetter D, Yee M, Mehran R, Bode C, Halperin J, Verheugt FW, Wildgoose P, Burton P, van Eickels M, Korjian S, Daaboul Y, Jain P, Lip GY, Cohen M, Peterson ED, Fox KA

doi: 10.1161/CIRCULATION

Thrombosis and Stroke

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

JAMA Intern Med

Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM, Tafur A, Lewis PA, Cohoon KP, Rahman H, Sison CP, Lesser ML, Ochani K, Agrawal N, Hsia J, Anderson VE, Bonaca M, Halperin JL, Weitz JI, HEP-COVID Investigators.

doi: 10.1001/jamainternmed.2021.6203

Hypertension

Clinical Outcomes After Intensifying Antihypertensive Medication Regimens Among Older Adults at Hospital Discharge

JAMA Intern Med.

Anderson TS, Jing B, Auerbach A, Wray CM, Lee S, Boscardin WJ, Fung K, Ngo S, Silvestrini M, Steinman MA

doi: 10.1001/jamainternmed.

Atrial FibrillationHeart, Artery and Coronary DiseasesMyocardial Infarction

Acute Noncardiovascular Illness in the Cardiac Intensive Care Unit

J Am Coll Cardiol.

Holland EM, Moss TJ

doi: 10.1016/j.jacc.2017.02.033.

Related content

Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients

Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During Hospitalization

Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure: The Atherosclerosis Risk in Communities Study

In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study

Pro Re Nata Antihypertensive Medications and Adverse Outcomes in Hospitalized Patients: A Propensity-Matched Cohort Study

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

Clinical Outcomes After Intensifying Antihypertensive Medication Regimens Among Older Adults at Hospital Discharge

Acute Noncardiovascular Illness in the Cardiac Intensive Care Unit